ARTICLE | Distillery Therapeutics
Therapeutics: Prostaglandin E2 (PGE2) receptor EP3 subtype (Prostanoid EP3 receptor; PTGER3)
February 26, 2015 8:00 AM UTC
Rodent studies suggest inhibiting PTGER3 could help treat pulmonary arterial hypertension (PAH). In two mouse models of PAH, PTGER3 knockout decreased markers of disease pathology compared with normal...